{"id":"https://openalex.org/W4382396967","doi":"https://doi.org/10.1136/ijgc-2023-004491","title":"A phase I study of the Wee1 kinase inhibitor adavosertib (AZD1775) in combination with chemoradiation in cervical, upper vaginal, and uterine cancers","display_name":"A phase I study of the Wee1 kinase inhibitor adavosertib (AZD1775) in combination with chemoradiation in cervical, upper vaginal, and uterine cancers","publication_year":2023,"publication_date":"2023-06-28","ids":{"openalex":"https://openalex.org/W4382396967","doi":"https://doi.org/10.1136/ijgc-2023-004491","pmid":"https://pubmed.ncbi.nlm.nih.gov/37380217","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/10711936"},"language":"en","primary_location":{"id":"doi:10.1136/ijgc-2023-004491","doi":"https://doi.org/10.1136/ijgc-2023-004491","is_oa":true,"landing_page_url":"https://doi.org/10.1136/ijgc-2023-004491","pdf_url":null,"source":{"id":"https://openalex.org/S41026820","display_name":"International Journal of Gynecological Cancer","issn_l":"1048-891X","issn":["1048-891X","1525-1438"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-2","poland-70","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319945","host_organization_name":"BMJ","host_organization_lineage":["https://openalex.org/P4310319945"],"host_organization_lineage_names":["BMJ"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"International Journal of Gynecological Cancer","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://doi.org/10.1136/ijgc-2023-004491","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5029102415","display_name":"Eduardo Gonz\u00e1lez-Ochoa","orcid":"https://orcid.org/0000-0002-1056-5967","observed_orcids":["https://orcid.org/0000-0002-1056-5967"]},"institutions":[{"id":"https://openalex.org/I2802654988","display_name":"Princess Margaret Cancer Centre","ror":"https://ror.org/03zayce58","country_code":"CA","type":"healthcare","lineage":["https://openalex.org/I1325899441","https://openalex.org/I2802654988"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"Eduardo Gonzalez-Ochoa","raw_affiliation_strings":["Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, Toronto, Ontario, Canada"],"raw_orcid":"https://orcid.org/0000-0002-1056-5967","affiliations":[{"raw_affiliation_string":"Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, Toronto, Ontario, Canada","institution_ids":["https://openalex.org/I2802654988"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5064900626","display_name":"Michael Milosevic","orcid":"https://orcid.org/0000-0002-9620-6876","observed_orcids":["https://orcid.org/0000-0002-9620-6876"]},"institutions":[{"id":"https://openalex.org/I2802654988","display_name":"Princess Margaret Cancer Centre","ror":"https://ror.org/03zayce58","country_code":"CA","type":"healthcare","lineage":["https://openalex.org/I1325899441","https://openalex.org/I2802654988"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"Michael Milosevic","raw_affiliation_strings":["Department of Radiation Oncology, Princess Margaret Hospital Cancer Centre, Toronto, Ontario, Canada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Radiation Oncology, Princess Margaret Hospital Cancer Centre, Toronto, Ontario, Canada","institution_ids":["https://openalex.org/I2802654988"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5040451836","display_name":"Bradley R. Corr","orcid":"https://orcid.org/0000-0002-6608-2585","observed_orcids":["https://orcid.org/0000-0002-6608-2585"]},"institutions":[{"id":"https://openalex.org/I51713134","display_name":"University of Colorado Anschutz","ror":"https://ror.org/03wmf1y16","country_code":"US","type":"education","lineage":["https://openalex.org/I51713134"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Bradley Corr","raw_affiliation_strings":["Division of Gynecologic Oncology, University of Colorado School of Medicine, Aurora, Colorado, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Gynecologic Oncology, University of Colorado School of Medicine, Aurora, Colorado, USA","institution_ids":["https://openalex.org/I51713134"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5087376683","display_name":"James L. Abbruzzese","orcid":"https://orcid.org/0000-0001-9223-2965","observed_orcids":["https://orcid.org/0000-0001-9223-2965"]},"institutions":[{"id":"https://openalex.org/I170897317","display_name":"Duke University","ror":"https://ror.org/00py81415","country_code":"US","type":"education","lineage":["https://openalex.org/I170897317"]},{"id":"https://openalex.org/I4390039326","display_name":"Duke Cancer Institute","ror":"https://ror.org/04vt65461","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210126298","https://openalex.org/I4210144876","https://openalex.org/I4390039326"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"James L. Abbruzzese","raw_affiliation_strings":["Division of Medical Oncology, Duke Cancer Institute, Durham, North Carolina, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Medical Oncology, Duke Cancer Institute, Durham, North Carolina, USA","institution_ids":["https://openalex.org/I170897317","https://openalex.org/I4390039326"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5055824335","display_name":"Eugenia Girda","orcid":"https://orcid.org/0000-0002-4787-5475","observed_orcids":["https://orcid.org/0000-0002-4787-5475"]},"institutions":[{"id":"https://openalex.org/I4390039325","display_name":"Rutgers Cancer Institute","ror":"https://ror.org/0060x3y55","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I102322142","https://openalex.org/I4390039302","https://openalex.org/I4390039325"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Eugenia Girda","raw_affiliation_strings":["Division of Gynecologic Oncology, Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Gynecologic Oncology, Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey, USA","institution_ids":["https://openalex.org/I4390039325"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5041798093","display_name":"Rachel W. Miller","orcid":"https://orcid.org/0000-0002-9417-6642","observed_orcids":["https://orcid.org/0000-0002-9417-6642"]},"institutions":[{"id":"https://openalex.org/I143302722","display_name":"University of Kentucky","ror":"https://ror.org/02k3smh20","country_code":"US","type":"education","lineage":["https://openalex.org/I143302722"]},{"id":"https://openalex.org/I2802239656","display_name":"Markey Cancer Center","ror":"https://ror.org/01dhvva97","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1285210727","https://openalex.org/I143302722","https://openalex.org/I2802239656"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Rachel W. Miller","raw_affiliation_strings":["Division of Gynecologic Oncology, University of Kentucky Markey Cancer Center, Lexington, Kentucky, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Gynecologic Oncology, University of Kentucky Markey Cancer Center, Lexington, Kentucky, USA","institution_ids":["https://openalex.org/I143302722","https://openalex.org/I2802239656"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5032770101","display_name":"Jennifer M. Croke","orcid":"https://orcid.org/0000-0002-7090-6313","observed_orcids":["https://orcid.org/0000-0002-7090-6313"]},"institutions":[{"id":"https://openalex.org/I2802654988","display_name":"Princess Margaret Cancer Centre","ror":"https://ror.org/03zayce58","country_code":"CA","type":"healthcare","lineage":["https://openalex.org/I1325899441","https://openalex.org/I2802654988"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"Jennifer Croke","raw_affiliation_strings":["Department of Radiation Oncology, Princess Margaret Hospital Cancer Centre, Toronto, Ontario, Canada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Radiation Oncology, Princess Margaret Hospital Cancer Centre, Toronto, Ontario, Canada","institution_ids":["https://openalex.org/I2802654988"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5049940232","display_name":"Helen J MacKay","orcid":"https://orcid.org/0000-0001-6220-1789","observed_orcids":["https://orcid.org/0000-0001-6220-1789"]},"institutions":[{"id":"https://openalex.org/I1323843004","display_name":"Sunnybrook Health Science Centre","ror":"https://ror.org/03wefcv03","country_code":"CA","type":"healthcare","lineage":["https://openalex.org/I1323843004"]},{"id":"https://openalex.org/I4405271711","display_name":"Odette Cancer Centre","ror":"https://ror.org/02ww1s787","country_code":"CA","type":"healthcare","lineage":["https://openalex.org/I1323843004","https://openalex.org/I4405271711"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"Helen Mackay","raw_affiliation_strings":["Division of Medical Oncology and Hematology, Sunnybrook Odette Cancer Centre, Toronto, Ontario, Canada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Medical Oncology and Hematology, Sunnybrook Odette Cancer Centre, Toronto, Ontario, Canada","institution_ids":["https://openalex.org/I1323843004","https://openalex.org/I4405271711"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5078365633","display_name":"Yeh Chen Lee","orcid":"https://orcid.org/0000-0003-2009-8263","observed_orcids":["https://orcid.org/0000-0003-2009-8263"]},"institutions":[{"id":"https://openalex.org/I31746571","display_name":"UNSW Sydney","ror":"https://ror.org/03r8z3t63","country_code":"AU","type":"education","lineage":["https://openalex.org/I31746571"]}],"countries":["AU"],"is_corresponding":false,"raw_author_name":"Yeh Chen Lee","raw_affiliation_strings":["University of New South Wales Prince of Wales Clinical School, Randwick, New South Wales, Australia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of New South Wales Prince of Wales Clinical School, Randwick, New South Wales, Australia","institution_ids":["https://openalex.org/I31746571"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5021338846","display_name":"Valerie Lydia Bowering","orcid":"https://orcid.org/0000-0003-0910-5186","observed_orcids":["https://orcid.org/0000-0003-0910-5186"]},"institutions":[{"id":"https://openalex.org/I2802654988","display_name":"Princess Margaret Cancer Centre","ror":"https://ror.org/03zayce58","country_code":"CA","type":"healthcare","lineage":["https://openalex.org/I1325899441","https://openalex.org/I2802654988"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"Valerie Bowering","raw_affiliation_strings":["Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, Toronto, Ontario, Canada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, Toronto, Ontario, Canada","institution_ids":["https://openalex.org/I2802654988"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5090755083","display_name":"Janelle Ramsahai","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2802654988","display_name":"Princess Margaret Cancer Centre","ror":"https://ror.org/03zayce58","country_code":"CA","type":"healthcare","lineage":["https://openalex.org/I1325899441","https://openalex.org/I2802654988"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"Janelle Ramsahai","raw_affiliation_strings":["Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, Toronto, Ontario, Canada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, Toronto, Ontario, Canada","institution_ids":["https://openalex.org/I2802654988"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5028677586","display_name":"Lisa E. Wang","orcid":"https://orcid.org/0000-0001-9726-0383","observed_orcids":["https://orcid.org/0000-0001-9726-0383"]},"institutions":[{"id":"https://openalex.org/I2802654988","display_name":"Princess Margaret Cancer Centre","ror":"https://ror.org/03zayce58","country_code":"CA","type":"healthcare","lineage":["https://openalex.org/I1325899441","https://openalex.org/I2802654988"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"Lisa Wang","raw_affiliation_strings":["Department of Biostatistics, Princess Margaret Cancer Cancer Centre, Toronto, Ontario, Canada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Biostatistics, Princess Margaret Cancer Cancer Centre, Toronto, Ontario, Canada","institution_ids":["https://openalex.org/I2802654988"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108846941","display_name":"April D'Souza","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2802654988","display_name":"Princess Margaret Cancer Centre","ror":"https://ror.org/03zayce58","country_code":"CA","type":"healthcare","lineage":["https://openalex.org/I1325899441","https://openalex.org/I2802654988"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"April D'Souza","raw_affiliation_strings":["Drug Development Program, Princess Margaret Cancer Centre, Toronto, Ontario, Canada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Drug Development Program, Princess Margaret Cancer Centre, Toronto, Ontario, Canada","institution_ids":["https://openalex.org/I2802654988"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5042269391","display_name":"Charles A. Kunos","orcid":"https://orcid.org/0009-0004-4056-9004","observed_orcids":["https://orcid.org/0009-0004-4056-9004"]},"institutions":[{"id":"https://openalex.org/I4210140884","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210140884"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Charles A. Kunos","raw_affiliation_strings":["National Cancer Institute Cancer Therapy Evaluation Program, Bethesda, Maryland, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"National Cancer Institute Cancer Therapy Evaluation Program, Bethesda, Maryland, USA","institution_ids":["https://openalex.org/I4210140884"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5072712459","display_name":"Amit M. Oza","orcid":"https://orcid.org/0000-0002-9510-8641","observed_orcids":["https://orcid.org/0000-0002-9510-8641"]},"institutions":[{"id":"https://openalex.org/I2802654988","display_name":"Princess Margaret Cancer Centre","ror":"https://ror.org/03zayce58","country_code":"CA","type":"healthcare","lineage":["https://openalex.org/I1325899441","https://openalex.org/I2802654988"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"Amit M. Oza","raw_affiliation_strings":["Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, Toronto, Ontario, Canada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, Toronto, Ontario, Canada","institution_ids":["https://openalex.org/I2802654988"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5031076350","display_name":"St\u00e9phanie Lheureux","orcid":"https://orcid.org/0000-0003-4405-5890","observed_orcids":["https://orcid.org/0000-0003-4405-5890"]},"institutions":[{"id":"https://openalex.org/I2802654988","display_name":"Princess Margaret Cancer Centre","ror":"https://ror.org/03zayce58","country_code":"CA","type":"healthcare","lineage":["https://openalex.org/I1325899441","https://openalex.org/I2802654988"]}],"countries":["CA"],"is_corresponding":true,"raw_author_name":"Stephanie Lheureux","raw_affiliation_strings":["Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, Toronto, Ontario, Canada Stephanie.Lheureux@uhn.ca","Princess Margaret Hospital Cancer Centre, Toronto M5G 1Z5, Ontario, Canada"],"raw_orcid":"https://orcid.org/0000-0002-9955-1245","affiliations":[{"raw_affiliation_string":"Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, Toronto, Ontario, Canada Stephanie.Lheureux@uhn.ca","institution_ids":["https://openalex.org/I2802654988"]},{"raw_affiliation_string":"Princess Margaret Hospital Cancer Centre, Toronto M5G 1Z5, Ontario, Canada","institution_ids":["https://openalex.org/I2802654988"]}]}],"institutions":[],"countries_distinct_count":3,"institutions_distinct_count":11,"corresponding_author_ids":["https://openalex.org/A5031076350"],"corresponding_institution_ids":["https://openalex.org/I2802654988"],"apc_list":{"value":3800,"currency":"USD","value_usd":3800},"apc_paid":null,"fwci":4.3792,"has_fulltext":true,"cited_by_count":16,"citation_normalized_percentile":{"value":0.95382963,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":97,"max":99},"biblio":{"volume":"33","issue":"8","first_page":"1208","last_page":"1214"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10668","display_name":"Endometrial and Cervical Cancer Treatments","score":0.9829000234603882,"subfield":{"id":"https://openalex.org/subfields/2729","display_name":"Obstetrics and Gynecology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10668","display_name":"Endometrial and Cervical Cancer Treatments","score":0.9829000234603882,"subfield":{"id":"https://openalex.org/subfields/2729","display_name":"Obstetrics and Gynecology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10146","display_name":"Cervical Cancer and HPV Research","score":0.0032999999821186066,"subfield":{"id":"https://openalex.org/subfields/2713","display_name":"Epidemiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11914","display_name":"PARP inhibition in cancer therapy","score":0.0012000000569969416,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/adavosertib","display_name":"adavosertib","score":0.9959999918937683},{"id":"https://openalex.org/keywords/azd1775","display_name":"AZD1775","score":0.996999979019165},{"id":"https://openalex.org/keywords/wee1-kinase-inhibitor","display_name":"Wee1 kinase inhibitor","score":0.996999979019165},{"id":"https://openalex.org/keywords/chemoradiotherapy","display_name":"chemoradiotherapy","score":0.8790000081062317},{"id":"https://openalex.org/keywords/cisplatin","display_name":"cisplatin","score":0.699999988079071},{"id":"https://openalex.org/keywords/pelvic-radiotherapy","display_name":"pelvic radiotherapy","score":0.7770000100135803},{"id":"https://openalex.org/keywords/cervical-cancer","display_name":"cervical cancer","score":0.8809999823570251},{"id":"https://openalex.org/keywords/endometrial-cancer","display_name":"endometrial cancer","score":0.9700000286102295},{"id":"https://openalex.org/keywords/vaginal-cancer","display_name":"vaginal cancer","score":0.9190000295639038},{"id":"https://openalex.org/keywords/g2-m-checkpoint","display_name":"G2/M checkpoint","score":0.9100000262260437},{"id":"https://openalex.org/keywords/dose-limiting-toxicity","display_name":"dose-limiting toxicity","score":0.9020000100135803},{"id":"https://openalex.org/keywords/thrombocytopenia","display_name":"thrombocytopenia","score":0.9229999780654907},{"id":"https://openalex.org/keywords/diarrhea","display_name":"diarrhea","score":0.8650000095367432},{"id":"https://openalex.org/keywords/recommended-phase-ii-dose","display_name":"recommended phase 2 dose","score":0.7739999890327454},{"id":"https://openalex.org/keywords/dose-escalation","display_name":"dose escalation","score":0.5529999732971191}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9364911317825317},{"id":"https://openalex.org/C2778220009","wikidata":"https://www.wikidata.org/wiki/Q160105","display_name":"Cervical cancer","level":3,"score":0.624492347240448},{"id":"https://openalex.org/C2777088508","wikidata":"https://www.wikidata.org/wiki/Q944777","display_name":"Endometrial cancer","level":3,"score":0.5783195495605469},{"id":"https://openalex.org/C29730261","wikidata":"https://www.wikidata.org/wiki/Q274160","display_name":"Toxicity","level":2,"score":0.4833623766899109},{"id":"https://openalex.org/C203092338","wikidata":"https://www.wikidata.org/wiki/Q1340863","display_name":"Clinical endpoint","level":3,"score":0.4822026491165161},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.48115837574005127},{"id":"https://openalex.org/C2775908122","wikidata":"https://www.wikidata.org/wiki/Q3070621","display_name":"External beam radiotherapy","level":4,"score":0.47487232089042664},{"id":"https://openalex.org/C126894567","wikidata":"https://www.wikidata.org/wiki/Q105650","display_name":"Urology","level":1,"score":0.46802788972854614},{"id":"https://openalex.org/C2778496288","wikidata":"https://www.wikidata.org/wiki/Q6931269","display_name":"Mucositis","level":3,"score":0.45493870973587036},{"id":"https://openalex.org/C2781252693","wikidata":"https://www.wikidata.org/wiki/Q7979264","display_name":"Wee1","level":5,"score":0.4412876069545746},{"id":"https://openalex.org/C2778239845","wikidata":"https://www.wikidata.org/wiki/Q412415","display_name":"Cisplatin","level":3,"score":0.4163539409637451},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.4109591841697693},{"id":"https://openalex.org/C509974204","wikidata":"https://www.wikidata.org/wiki/Q180507","display_name":"Radiation therapy","level":2,"score":0.35744112730026245},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.33341652154922485},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.3214521110057831},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.28141409158706665},{"id":"https://openalex.org/C2777416452","wikidata":"https://www.wikidata.org/wiki/Q896687","display_name":"Brachytherapy","level":3,"score":0.22140854597091675},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.21800920367240906},{"id":"https://openalex.org/C29537977","wikidata":"https://www.wikidata.org/wiki/Q188941","display_name":"Cell cycle","level":3,"score":0.0},{"id":"https://openalex.org/C120504264","wikidata":"https://www.wikidata.org/wiki/Q1147372","display_name":"Cyclin-dependent kinase 1","level":4,"score":0.0}],"mesh":[{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D000971","descriptor_name":"Antineoplastic Combined Chemotherapy Protocols","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D002583","descriptor_name":"Uterine Cervical Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D002583","descriptor_name":"Uterine Cervical Neoplasms","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":true},{"descriptor_ui":"D002945","descriptor_name":"Cisplatin","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011720","descriptor_name":"Pyrazoles","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011744","descriptor_name":"Pyrimidinones","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013921","descriptor_name":"Thrombocytopenia","qualifier_ui":"Q000139","qualifier_name":"chemically induced","is_major_topic":true},{"descriptor_ui":"D013921","descriptor_name":"Thrombocytopenia","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D047428","descriptor_name":"Protein Kinase Inhibitors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":3,"locations":[{"id":"doi:10.1136/ijgc-2023-004491","doi":"https://doi.org/10.1136/ijgc-2023-004491","is_oa":true,"landing_page_url":"https://doi.org/10.1136/ijgc-2023-004491","pdf_url":null,"source":{"id":"https://openalex.org/S41026820","display_name":"International Journal of Gynecological Cancer","issn_l":"1048-891X","issn":["1048-891X","1525-1438"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-2","poland-70","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319945","host_organization_name":"BMJ","host_organization_lineage":["https://openalex.org/P4310319945"],"host_organization_lineage_names":["BMJ"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"International Journal of Gynecological Cancer","raw_type":"journal-article"},{"id":"pmid:37380217","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/37380217","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"International journal of gynecological cancer : official journal of the International Gynecological Cancer Society","raw_type":"Clinical Trial, Phase I"},{"id":"pmh:oai:pubmedcentral.nih.gov:10711936","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/10711936","pdf_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC10711936/pdf/nihms-1926552.pdf","source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"Int J Gynecol Cancer","raw_type":"Text"}],"best_oa_location":{"id":"doi:10.1136/ijgc-2023-004491","doi":"https://doi.org/10.1136/ijgc-2023-004491","is_oa":true,"landing_page_url":"https://doi.org/10.1136/ijgc-2023-004491","pdf_url":null,"source":{"id":"https://openalex.org/S41026820","display_name":"International Journal of Gynecological Cancer","issn_l":"1048-891X","issn":["1048-891X","1525-1438"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-2","poland-70","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319945","host_organization_name":"BMJ","host_organization_lineage":["https://openalex.org/P4310319945"],"host_organization_lineage_names":["BMJ"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"International Journal of Gynecological Cancer","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","score":1.0,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Clinical Trial","id":"https://openalex.org/study-designs/clinical-trial"}],"awards":[{"id":"https://openalex.org/G8549699457","display_name":null,"funder_award_id":"N01-CM-2011-0032","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"},{"id":"https://openalex.org/G9000879312","display_name":"North American Star Consortium","funder_award_id":"UM1CA186644","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"},{"id":"https://openalex.org/G9000884540","display_name":"The Johns Hopkins Translational Science Team and Consortium for ETCTN Studies","funder_award_id":"UM1CA186691","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"}],"funders":[{"id":"https://openalex.org/F4320307105","display_name":"Amgen","ror":"https://ror.org/03g03ge92"},{"id":"https://openalex.org/F4320307765","display_name":"Pfizer","ror":"https://ror.org/01xdqrp08"},{"id":"https://openalex.org/F4320307770","display_name":"AstraZeneca","ror":"https://ror.org/04r9x1a08"},{"id":"https://openalex.org/F4320308573","display_name":"Gilead Sciences","ror":"https://ror.org/056546b03"},{"id":"https://openalex.org/F4320311600","display_name":"Regeneron Pharmaceuticals","ror":"https://ror.org/02f51rf24"},{"id":"https://openalex.org/F4320313690","display_name":"Novocure","ror":"https://ror.org/018ec2p66"},{"id":"https://openalex.org/F4320319515","display_name":"Seagen","ror":null},{"id":"https://openalex.org/F4320322148","display_name":"Eisai","ror":"https://ror.org/04vvh7p27"},{"id":"https://openalex.org/F4320328062","display_name":"MorphoSys","ror":"https://ror.org/00ew7rg06"},{"id":"https://openalex.org/F4320337351","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81"}],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4382396967.pdf","grobid_xml":"https://content.openalex.org/works/W4382396967.grobid-xml"},"referenced_works_count":35,"referenced_works":["https://openalex.org/W1606643601","https://openalex.org/W1927580531","https://openalex.org/W1935824237","https://openalex.org/W2028495676","https://openalex.org/W2029080338","https://openalex.org/W2035263093","https://openalex.org/W2086255242","https://openalex.org/W2093814864","https://openalex.org/W2096293110","https://openalex.org/W2111222453","https://openalex.org/W2157719711","https://openalex.org/W2166767010","https://openalex.org/W2314753133","https://openalex.org/W2324392028","https://openalex.org/W2328935341","https://openalex.org/W2507880355","https://openalex.org/W2562446577","https://openalex.org/W2835635281","https://openalex.org/W2952695966","https://openalex.org/W2963015093","https://openalex.org/W2968502728","https://openalex.org/W2981454426","https://openalex.org/W3026350705","https://openalex.org/W3030611069","https://openalex.org/W3088023343","https://openalex.org/W3127968645","https://openalex.org/W3128646645","https://openalex.org/W3166483804","https://openalex.org/W3188008250","https://openalex.org/W3200231835","https://openalex.org/W3203488151","https://openalex.org/W4302424483","https://openalex.org/W4312139816","https://openalex.org/W6769496349","https://openalex.org/W6790598159"],"related_works":["https://openalex.org/W2981454426","https://openalex.org/W2955855630","https://openalex.org/W4323044182","https://openalex.org/W4376224383","https://openalex.org/W3188008250","https://openalex.org/W3011273846","https://openalex.org/W4285698465","https://openalex.org/W4379509021","https://openalex.org/W3155549599","https://openalex.org/W3004857819"],"abstract_inverted_index":null,"counts_by_year":[{"year":2026,"cited_by_count":7},{"year":2025,"cited_by_count":4},{"year":2024,"cited_by_count":5}],"updated_date":"2026-11-07T11:25:07.637180","created_date":"2023-06-29T00:00:00"}